Insider Selling: Premier, Inc. (NASDAQ:PINC) Director Sells $53,550.00 in Stock

Premier, Inc. (NASDAQ:PINC) Director Helen M. Boudreau sold 2,500 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $21.42, for a total value of $53,550.00. Following the completion of the transaction, the director now owns 20,668 shares in the company, valued at $442,708.56. The trade was a 10.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Premier Stock Performance

Shares of NASDAQ:PINC opened at $21.16 on Friday. Premier, Inc. has a 52 week low of $17.95 and a 52 week high of $23.56. The company has a market capitalization of $2.03 billion, a PE ratio of 15.56 and a beta of 0.43. The company has a 50 day moving average price of $21.99 and a two-hundred day moving average price of $20.51.

Premier (NASDAQ:PINC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.25 by $0.09. Premier had a return on equity of 10.74% and a net margin of 11.41%. The business had revenue of $248.14 million for the quarter, compared to the consensus estimate of $232.85 million. During the same quarter last year, the business posted $0.50 EPS. The firm’s revenue was down 7.8% compared to the same quarter last year. On average, sell-side analysts forecast that Premier, Inc. will post 1.09 earnings per share for the current year.

Premier Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Sunday, December 15th. Investors of record on Sunday, December 1st were paid a dividend of $0.21 per share. The ex-dividend date was Friday, November 29th. This represents a $0.84 dividend on an annualized basis and a yield of 3.97%. Premier’s payout ratio is 61.76%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on PINC. StockNews.com cut Premier from a “buy” rating to a “hold” rating in a report on Tuesday, November 5th. Robert W. Baird raised their target price on shares of Premier from $19.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, November 6th. Canaccord Genuity Group boosted their price target on shares of Premier from $19.00 to $21.00 and gave the stock a “hold” rating in a research note on Wednesday, November 6th. Finally, Barclays raised their price objective on shares of Premier from $20.00 to $24.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 6th. Ten investment analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Premier presently has a consensus rating of “Hold” and an average target price of $21.36.

Institutional Trading of Premier

Hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC increased its position in shares of Premier by 137.6% during the third quarter. GAMMA Investing LLC now owns 1,347 shares of the company’s stock worth $27,000 after acquiring an additional 780 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Premier in the 3rd quarter worth $39,000. Quarry LP raised its stake in shares of Premier by 576.7% in the 3rd quarter. Quarry LP now owns 2,179 shares of the company’s stock valued at $44,000 after purchasing an additional 1,857 shares during the period. Meeder Asset Management Inc. acquired a new stake in shares of Premier in the 2nd quarter valued at about $47,000. Finally, Abich Financial Wealth Management LLC lifted its holdings in shares of Premier by 37.0% in the second quarter. Abich Financial Wealth Management LLC now owns 2,672 shares of the company’s stock valued at $50,000 after purchasing an additional 721 shares in the last quarter. 74.41% of the stock is currently owned by institutional investors and hedge funds.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.